Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ERYTHROPOIETIN
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : Shahid Beheshti University of Medical Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
December 06, 2016
Lead Product(s) : ERYTHROPOIETIN
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : Shahid Beheshti University of Medical Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable